|
 |
gadoversetamideThis page contains recent news articles, when available, and an overview of gadoversetamide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....(RTTNews) - Covidien Plc (COV: News ) stated that it will voluntarily contraindicate the use of its Optimark gadoversetamide injection, a gadolinium-based ... RTT News Covidien Adds Kidney Disease Risk to its Imaging Agent - Nov 11, 2009 Optimark gadoversetamide injection is a gadolinium-based contrast agent (GBCA) used in magnetic resonance imaging (MRI) procedures. ... Renal Business Today Covidien Submitting Label Change For Optimark Risk (COV) - Nov 9, 2009 ...the use of its Optimark gadoversetamide injection in magnetic resonance imaging procedures involving patients with severe renal impairment. ... Trading Markets (press release) Is late gandolinium enhancement MRI an effective method of detecting ... - Mar 11, 2008 Kim RJ et al. for the Gadoversetamide Myocardial Infarction Imaging ... Late gandolinium enhancement MRI (LGE-MRI) with gadoversetamide has the potential to ... Nature.com gadoversetamide Mallinckrodt completes phase II trials.(Brief Article) - Mar 21, 2005 Mallinckrodt reported on 8 March 2005 that it has completed two international phase II trials of gadoversetamide (OptiMARK ) injection, ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Magnetic Resonance Imaging Contrast Agents (Diagnostic ). - Oct 27, 2005 Gadoversetamide is also used to help diagnose problems in the liver. MRI contrast agents may also be used to diagnose other conditions as determined by your ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com … Optimark Imaging Agent (Gadoversetamide Inj., USP) Completes Phase... - Mar 8, 2005 ORLANDO, Fla., March 8 /PRNewswire/ -- Mallinckrodt, a business unit of Tyco Healthcare, today announced the successful completion of two Phase II studies ... $4.95 - PR Newswire - ECNext FDA Orders Black Box Warning for Gadolinium-Based Contrast Agents - May 23, 2007 Gadodiamide was the most commonly reported agent, when a specific agent was identified, followed by gadopentetate dimeglumine and gadoversetamide. ... MedPage Today OptiMARK, un mezzo di contrasto per la risonanza magnetica per … - Oct 9, 2007 Il principio attivo di OptiMARK, Gadoversetamide, contiene Gadolinio, un metallo delle cosiddette terre rare. Il Gadolinio è usato come mezzo di contrasto ... XagenaSalute MRI Contrast Agents May Pose Risk for Patients With Kidney Disease - Jan 17, 2007 ...gadopentetate dimeglumine (Magnevist), 2 with gadoversetamide (OptiMARK), 3 with gadodiamide and gadoversetamide, and 3 with unknown contrast agents. ... Journal of American Medical Association - Journal of American Medical Association... ì‹ ìž¥ì„± ì„¬ìœ í”¼ë¶€ì§ˆí™˜ì?¸ NSFë°œìƒ?위험 ë³´ê³ ë”°ë?¼ - Oct 4, 2007 ...현재 GBCA ì¡°ì˜?ì œë¡œëŠ” GE Healthcare사ì?˜ Omniscan (gadodiamide), ì‰?ë§?ì?˜ Magnevist (gadopentetate dimeglumine), 마린í?¬ë¡œíŠ¸ì‚¬ì?˜ OptiMark(gadoversetamide) 브로코 ... 메디í?¬ë‰´ìŠ¤ TEXT-EU agency details decisions on new drugs - May 25, 2007 Optimark (gadoversetamide), from Tyco Healthcare Deutschland GmbH, for use in magnetic resonance imaging. EMEA review began on 24 May 2006 with an active ... Reuters Progressive arm and leg stiffness in a patient with chronic renal … - Feb 5, 2008 ...gadodiamide (Omniscan ® [GE Healthcare, Oslo, Norway]), gadopentetate dimeglumine (Magnevist ® ), and gadoversetamide (OptiMARK ® [Mallinckrodt, ... Nature.com Mallinckrodt Signs New Imaging and Radiopharmaceutical Agreements … - Jan 3, 2007 Also for the first time, the company's OptiMARK(R) (gadoversetamide injection) magnetic resonance contrast agent will be available under contract to all ... EETimes.com Tyco Healthcare / Mallinckrodt and IRadimed Announce North American … - May 11, 2006 Mallinckrodt's dedicated sales specialists are particularly knowledgeable about MRI, given their experience selling OptiMARK(R) (gadoversetamide injection) ... ereleases.com NSF NFD Gadolinium Lawyers offer Nationwide Assistance to Patients - Jan 17, 2008 Magnevist (gadopentetate dimeglumine), Ominiscan (gadodiamide); OptiMARK (gadoversetamide); MultiHance;(gadobenate dimeglumine);and Prohance (gadoteridol). Press Media Wire - Press Media Wire (Press Release) Mallinckrodt, Inc., Hazelwood, MO, Oct. 13 (DDMAC).(HUMAN DRUGS & … - Nov 1, 2006 ...panels for Mallinckrodt's MD-Gastroview (diatrizoate meglumine and diatrizoate sodium solution USP) and OptiMARK (gadoversetamide injection) entitled, ... $4.95 - Warning Letter Bulletin - ECNext Article: Gadolinium and kidney disease: are your patients at risk?(Cli... - Mar 1, 2008 These agents are gadodimide (Omniscan[R]), gadoversetamide (OptiMARK[R]), gadopentetate dimeglumine (Magnevist[R]), gadoteridol (ProHance[R]), ... Pay-Per-View - Nephrology Nursing Journal - HighBeam Research Gadolinium-based MRI Contrast Agents Linked to Potentially Fatal … - Jul 4, 2007 Magnevist (gadopentetate dimeglumine), Ominiscan (gadodiamide); OptiMARK (gadoversetamide); MultiHance;(gadobenate dimeglumine);and Prohance (gadoteridol). prweb.com NSF After Gadolinium Imaging - Jan 15, 2007 GE Healthcare, Princeton, New Jersey), gadoversetamide (OptiMark, Mallinckrodt, St. Louis, Missouri), or gadopentetate dimeglumine (Magnevist, ... Medscape Europese registratie van geneesmiddelen in november 2008 - Nov 26, 2008 ...in gang gezet voor de twee centraal geregistreerde gadolinium bevattende contrastmiddelen, Optimark (gadoversetamide) en Vasovist (gadofosveset) apothekersnieuws.nl Georgia Code - 16-13-71. (a) A "dangerous drug" means any drug other ... - Aug 4, 2005 ...(408.3) Gadodiamide; (408.4) Gadopentetate dimeglumine; (408.6) Gadoteridol; (408.8) Gadoversetamide; (408.9) Galantamine; (409) Gallamine triethiodide; ... Pay-Per-View - Georgia Code - Loislaw FDA Requests Boxed Warning For Contrast Agents Used To Improve MRI … - May 30, 2007 ...(gadopentetate dimeglumine), Ominiscan (gadodiamide); OptiMARK (gadoversetamide); MultiHance;(gadobenate dimeglumine);and Prohance (gadoteridol). ... Medical News Today - Medical News Today (press release) FDA wants 'black box' warnings for certain MRI contrast agents - May 31, 2007 ...(gadopentetate dimeglumine), Ominiscan (gadodiamide); OptiMARK (gadoversetamide); MultiHance (gadobenate dimeglumine); and Prohance (gadoteridol). ... Free with registration - Diagnostic Update - AccessMyLibrary.com Current issues in contrast media administration – gadolinium compounds... - May 21, 2007 Some 200 such cases have been recorded over the past year, the majority related to the use of gadodiamide and gadoversetamide. At least six cases, however, ... European Hospital EMEA CMPH Use Adopts 5 Positive Opinions Recommending The … - May 29, 2007 Optimark (gadoversetamide), from Tyco Healthcare Deutschland GmbH, for use in magnetic resonance imaging. EMEA review began on 24 May 2006 with an active ... Medical News Today - Medical News Today (press release) Contrast Agent Linked to Fibrosing Disorder in Dialysis Patients - Oct 1, 2007 529 mg/mL, Omniscan (gadodiamide) injection, OptiMARK (gadoversetamide) injection, and ProHance (gadoteridol) injection, 279.3 mg/mL. MedPage Today FDA call for warning on contrast agents.(Brief article) - Jun 4, 2007 ...five such products have been approved for use in the USA: Magnevist (gadopentetate dimeglumine), Ominiscan (gadodiamide); OptiMARK (gadoversetamide); ... $4.95 - Pharma Marketletter - ECNext Press Release: Gadolinium-based MRI Contrast Agents Linked to … - Jul 3, 2007 ...(gadopentetate dimeglumine), Ominiscan (gadodiamide); OptiMARK (gadoversetamide); MultiHance;(gadobenate dimeglumine); and Prohance (gadoteridol). ... Pay-Per-View - PR Newswire - HighBeam Research Imaging the augmented breast.(CASE STUDY)(Case study) - Jan 1, 2007 For this case, gadoversetamide, a paramagnetic gadolinium-based contrast agent (0.1 mmol/kg, OptiMARK, Tyco Healthcare, West Windsor, NJ), was administered ... $4.95 - Radiologic Technology - ECNext Press Release: FDA Grants Priority Review to PLAVIX(R) (Clopidogrel … - Jan 18, 2006 Article: Mallinckrodt's Optimark Imaging Agent (Gadoversetamide Inj., USP) ... PR Newswire; March 8, 2005 ; 700+ words ... ... medical centers. ... Pay-Per-View - PR Newswire - HighBeam Research |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |